# Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

> **NCT04595968** · NA · COMPLETED · sponsor: **Neurovalens Ltd.** · enrollment: 267 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Vestal DM Active device
- **BEHAVIORAL:** Lifestyle modification
- **DEVICE:** Vestal DM Sham device

## Key facts

- **NCT ID:** NCT04595968
- **Lead sponsor:** Neurovalens Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-21
- **Primary completion:** 2024-08-06
- **Final completion:** 2024-08-06
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595968, "Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04595968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*